For more information please contact +1 (888) 605-6579


Reports of patients contracting tuberculosis are becoming more common. Once thought to be eradicated, this disease is making a come back in the West. Tuberculosis is a common and sometimes lethal infectious disease caused by mycobacteria that attack the lungs and possibly other organs along the way. It can lie latent, but when active if untreated kills 50% of it’s victims. One third of the world’s population is thought to be infected, with 80% positive test results in developing Asian and African countries. However, only 5-10% of the population of the United States seems to carry the disease.

Tuberculosis and Live Cell Therapy

Patients with TB have a decrease in their immune cells and the killer cell activity. This is where immune modulation using cell therapy could provide hope for sufferers of TB. Some case studies have shown that patients undergoing immune modulation using thymus extract have shown an increase in the immune cell count and activity as well as experiencing an improvement in the clinical condition. Patient groups undergoing cell therapy show a larger number of individuals recovering from this disease. Due to these results, it has been suggested to add Cell Extract Therapy to the standard treatment protocols for tuberculosis.